Nov 3 (Reuters) - Generation Bio Co GBIO.O :
* GENERATION BIO REPORTS BUSINESS HIGHLIGHTS AND THIRD
QUARTER
2022 FINANCIAL RESULTS
* QTRLY NET LOSS WAS $31.3 MILLION, OR $0.53 BASIC AND
DILUTED NET
LOSS PER SHARE
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE
$301.2
MILLION AS OF SEPTEMBER 30, 2022
* COMPANY BELIEVES THAT ITS CASH POSITION WILL FUND ITS
OPERATING
PLAN INTO 2025
* Q3 EARNINGS PER SHARE VIEW $-0.67 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4ChnPb
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;))